Genetic polymorphisms in glutathione‐S‐transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma
Open Access
- 24 November 2004
- Vol. 103 (1), 52-58
- https://doi.org/10.1002/cncr.20729
Abstract
BACKGROUND It has been suggested that genetic polymorphisms in certain glutathione‐S‐transferase (GST) genes reduce the effectiveness of detoxifying cytotoxins generated by chemotherapeutic agents, potentially resulting in enhanced clinical responses to chemotherapy. METHODS The authors evaluated common polymorphisms in the GSTM1, GSTT1, and GSTP1 genes for associations with overall survival in 1034 patients with invasive breast carcinoma who were recruited into the Shanghai Breast Cancer Study between 1996 and 1998, treated with chemotherapy, and followed for a median of 5.3 years. RESULTS After adjusting for age, tumor stage, and the use of radiotherapy and tamoxifen, women who were homozygous for the variant GSTP1 105Val allele had a 60% reduction in mortality risk compared with women who were homozygous for the Ile allele (hazard ratio, 0.4; 95% confidence interval, 0.2–0.8). No association was found with respect to any of the GSTM1 or GSTT1 genotypes. CONCLUSIONS The results of the current study indicate a potential role for GSTP1 polymorphism in predicting the clinical outcomes of patients with breast carcinoma who are treated with chemotherapy. Cancer 2005. © 2004 American Cancer Society.Keywords
This publication has 25 references indexed in Scilit:
- Pharmacogenetics in the treatment of breast cancerThe Pharmacogenomics Journal, 2004
- Genetic Polymorphisms in the TGF- β 1 Gene and Breast Cancer SurvivalCancer Research, 2004
- Prognostic Significance of Glutathione S-Transferase-Pi in Invasive Breast CancerLaboratory Investigation, 2003
- Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemiaLeukemia, 2003
- Targeted therapy and pharmacogenomic programsCancer, 2003
- Pharmacogenetics in Cancer TreatmentAnnual Review of Medicine, 2003
- Association between a glutathione S‐transferase A1 promoter polymorphism and survival after breast cancer treatmentInternational Journal of Cancer, 2002
- Negative prognostic value of glutathione S-transferase(GSTM1 and GSTT1) deletions in adult acute myeloid leukemiaBlood, 2002
- Activity of Allelic Variants of Pi Class Human Glutathione S-Transferase Toward ChlorambucilBiochemical and Biophysical Research Communications, 2000
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part ICritical Reviews in Biochemistry and Molecular Biology, 1995